Literature DB >> 1625140

Esophageal tracheoplasty for congenital tracheal stenosis.

S Sasaki1, F Hara, T Ohwa, T Eguchi, A Masaoka.   

Abstract

Two infants with congenital long tracheal stenosis underwent operation by means of an esophageal tracheoplasty. The first patient had previously undergone tracheal reconstruction using the pericardium. Although ventilation improved somewhat following this procedure, the pericardial patch suddenly ruptured 12 days after the operation, requiring an immediate esophageal tracheoplasty. The esophageal portion of the reconstructed trachea epithelialized 1 month later, with the lumen maintaining its proper size. However, the patient died 3 months after the second tracheoplasty. The cause of death was thought to be due to complications arising from prolonged high-pressure use of mechanical ventilation. He had been on a respirator for 6 months before the first tracheoplasty. The second patient has been doing well with no recurring respiratory problems for 25 months now. Her reconstructed trachea has adapted with her growth. This technique should be considered along with other forms of treatment for tracheal reconstruction because it is relatively simple and pliable.

Entities:  

Mesh:

Year:  1992        PMID: 1625140     DOI: 10.1016/0022-3468(92)90468-m

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Esophageal patch tracheoplasty for congenital tracheal stenosis.

Authors:  Akira Masaoka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-02-13

2.  Management of suspected tracheobronchial stenosis in ventilated neonates.

Authors:  D Albert
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

3.  Tracheal reconstruction by re-inforced Gore-Tex in esophageal submuscular tunneling: An experimental study.

Authors:  Hossein Hodjati; Saeed Reza Baezzat; Afsoon Fazelzadeh; Nader Tanideh; Bita Geramizadeh
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.